This invention relates to the tigogenin cellobioside, tigogenin cellobioside heptaacetate and to the use of these compounds for treatment of hypercholesterolemia and atherosclerosis.
RELATED DISCLOSURES
French Pat. No. 2,425,859 and U.S. Pat. No. 4,260,603 describe the medicaments having activity as